Yorktown Management & Research Co Inc - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 85 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2018. The put-call ratio across all filers is 3.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Yorktown Management & Research Co Inc ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2018$320,000
-19.4%
4,0000.0%0.09%
-18.3%
Q2 2018$397,000
+22.5%
4,0000.0%0.12%
+19.8%
Q1 2018$324,0004,0000.10%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2018
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders